Francois Nantel
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Guselkumab Efficacy in Biologic-Naïve Participants with Psoriatic Arthritis and Severe Disease Activity: Post Hoc Analysis of a Phase 3 Study.
Journal: Rheumatology and therapy
Published: April 29, 2025
Impact of Adherence to Golimumab on Disease Flares in Rheumatoid Arthritis: Results from a Canadian Observational Study.
Journal: Patient preference and adherence
Published: January 24, 2025
Real-World Incidence and Determinants of Infection in Patients With Rheumatoid Arthritis Treated With Golimumab After a Median Follow-Up Time of 27 Months.
Journal: The Journal of rheumatology
Published: May 19, 2023
Usage and Adherence of Seven Advanced Therapies with Differing Mechanisms of Action for Inflammatory Arthritis in Canada.
Journal: Rheumatology and therapy
Published: March 11, 2022
Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry.
Journal: BMJ open
Published: August 15, 2020
Long-term effectiveness and safety of infliximab and golimumab in ankylosing spondylitis patients from a Canadian prospective observational registry.
Journal: BMC rheumatology
Published: June 01, 2020
Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry.
Journal: BMC rheumatology
Published: January 30, 2020
Toward Defining Primary and Secondary Nonresponse in Rheumatoid Arthritis Patients Treated with Anti-TNF: Results from the BioTRAC and OBRI Registries.
Journal: The Journal of rheumatology
Published: June 20, 2019
Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis.
Journal: Patient preference and adherence
Published: January 31, 2019
Incidence of infusion reactions to intravenous golimumab: results from a prospective, real-world community registry.
Journal: Clinical and experimental rheumatology
Published: October 16, 2018
Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab.
Journal: Rheumatology (Oxford, England)
Published: May 08, 2018
Adherence and dosing interval of subcutaneous antitumour necrosis factor biologics among patients with inflammatory arthritis: analysis from a Canadian administrative database.
Journal: BMJ open
Published: September 21, 2017
Last Updated: 09/26/2026